Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?
Journal of Alzheimer's Disease , Volume 41 - Issue 2 p. 641- 642
Alzheimer's disease is the most common form of dementia in the elderly. Currently, there is no established standard treatment for this disease; therefore, the treatment of Alzheimer's disease will be a major challenge for physicians in the next decade in order to ameliorate quality of life of patients and reduce the costs for the communities.
|Journal of Alzheimer's Disease|
|Organisation||Department of Internal Medicine|
Mattace Raso, F.U.S. (2014). Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?. Journal of Alzheimer's Disease (Vol. 41, pp. 641–642). doi:10.3233/JAD-140016